DiaSorin SpA Valuation
| DSRLF Stock | USD 106.85 0.32 0.30% |
At this time, the firm appears to be fairly valued. DiaSorin SpA shows a prevailing Real Value of $105.59 per share. The current price of the firm is $106.85. Our model computes the value of DiaSorin SpA from reviewing the firm fundamentals such as Operating Margin of 0.29 %, profit margin of 0.20 %, and Current Valuation of 8.64 B as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that DiaSorin SpA's price fluctuation is very steady at this time. Calculation of the real value of DiaSorin SpA is based on 3 months time horizon. Increasing DiaSorin SpA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DiaSorin pink sheet is determined by what a typical buyer is willing to pay for full or partial control of DiaSorin SpA. Since DiaSorin SpA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DiaSorin Pink Sheet. However, DiaSorin SpA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 106.85 | Real 105.59 | Hype 106.85 |
The real value of DiaSorin Pink Sheet, also known as its intrinsic value, is the underlying worth of DiaSorin SpA Company, which is reflected in its stock price. It is based on DiaSorin SpA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DiaSorin SpA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of DiaSorin SpA helps investors to forecast how DiaSorin pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DiaSorin SpA more accurately as focusing exclusively on DiaSorin SpA's fundamentals will not take into account other important factors: DiaSorin SpA Total Value Analysis
DiaSorin SpA is currently expected to have takeover price of 8.64 B with market capitalization of 7.15 B, debt of 1.23 B, and cash on hands of 382.44 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DiaSorin SpA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.64 B | 7.15 B | 1.23 B | 382.44 M |
DiaSorin SpA Investor Information
About 58.0% of the company shares are held by company insiders. The book value of DiaSorin SpA was currently reported as 30.1. The company recorded earning per share (EPS) of 5.34. DiaSorin SpA last dividend was issued on the 23rd of May 2022. Based on the key measurements obtained from DiaSorin SpA's financial statements, DiaSorin SpA is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.DiaSorin SpA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DiaSorin SpA has an asset utilization ratio of 38.3 percent. This implies that the Company is making $0.38 for each dollar of assets. An increasing asset utilization means that DiaSorin SpA is more efficient with each dollar of assets it utilizes for everyday operations.DiaSorin SpA Ownership Allocation
DiaSorin SpA holds a total of 53.84 Million outstanding shares. DiaSorin SpA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.DiaSorin SpA Profitability Analysis
The company reported the revenue of 1.24 B. Net Income was 310.97 M with profit before overhead, payroll, taxes, and interest of 824.77 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DiaSorin SpA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DiaSorin SpA and how it compares across the competition.
About DiaSorin SpA Valuation
The pink sheet valuation mechanism determines DiaSorin SpA's current worth on a weekly basis. Our valuation model uses a comparative analysis of DiaSorin SpA. We calculate exposure to DiaSorin SpA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DiaSorin SpA's related companies.DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN SPA operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 3350 people.
8 Steps to conduct DiaSorin SpA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DiaSorin SpA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DiaSorin SpA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DiaSorin SpA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DiaSorin SpA's revenue streams: Identify DiaSorin SpA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DiaSorin SpA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DiaSorin SpA's growth potential: Evaluate DiaSorin SpA's management, business model, and growth potential.
- Determine DiaSorin SpA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DiaSorin SpA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
DiaSorin SpA Growth Indicators
Investing in growth stocks can be very risky. If the company such as DiaSorin SpA does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 54.8 M | |
| Quarterly Earnings Growth Y O Y | -0.169 | |
| Forward Price Earnings | 30.581 | |
| Retained Earnings | 1.3 B |
Complementary Tools for DiaSorin Pink Sheet analysis
When running DiaSorin SpA's price analysis, check to measure DiaSorin SpA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaSorin SpA is operating at the current time. Most of DiaSorin SpA's value examination focuses on studying past and present price action to predict the probability of DiaSorin SpA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaSorin SpA's price. Additionally, you may evaluate how the addition of DiaSorin SpA to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |